Price T Rowe Associates Inc Corcept Therapeutics Inc Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 51,135 shares of CORT stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,135

Previous 48,426 5.59%

Holding current value

$2.37 Million

Previous $1.22 Million 36.23%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $60,166 - $93,406	2,709 Added 5.59%	51,135 $1.66 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $65,599 - $85,373	-3,109 Reduced 6.03%	48,426 $1.22 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $70,737 - $93,708	2,850 Added 5.85%	51,535 $1.67 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $44,862 - $69,019	2,042 Added 4.38%	48,685 $1.33 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $17,838 - $20,924	832 Added 1.82%	46,643 $1.04 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $42,259 - $53,858	2,201 Added 5.05%	45,811 $993,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $41,535 - $62,376	2,082 Added 5.01%	43,610 $886,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $141,555 - $166,886	5,731 Added 16.01%	41,528 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $125,295 - $182,919	7,230 Added 25.31%	35,797 $851,000
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $66,615 - $101,596	4,030 Added 16.42%	28,567 $643,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $311,664 - $425,394	-18,226 Reduced 42.62%	24,537 $486,000
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $3,936 - $4,506	200 Added 0.47%	42,763 $842,000
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $31,173 - $38,135	1,561 Added 3.81%	42,563 $936,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $3,171 - $4,125	-135 Reduced 0.33%	41,002 $975,000
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $690,278 - $1.12 Million	41,137 New	41,137 $1.08 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.95B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Corcept Therapeutics Inc Transaction History